Pharma Stock Eyes Best Day Ever on Successful Trial

The security is up more than 47% so far in 2023

Digital Content Manager
Sep 11, 2023 at 10:57 AM
facebook X logo linkedin


Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) stock is surging today, last seen up 72.7% to trade at $27.58 at last check, after the late stage trial for its experimental drug paltusotine to treat a rare hormonal disorder was successful. The company also plans to submit a regulatory approval application to the Food and Drug Administration (FDA) next year, should another late-stage trial go well.

Oppenheimer and Evercore ISI raised their price targets to $46 from $48, respectively. The brokerage bunch leans bullish on CRNX, with all eight of the analysts in coverage boasting a "strong buy" rating, while the 12-month consensus target price of $46.50 is now a 72.3% premium to current levels. 

The security is today pacing for its best single-day percentage gain on record, after hitting a four-year high of $29.45. Shares have also conquered overhead pressure at their 40-day moving average, which first came into place in mid-June. So far in 2023, CRNX is up 47.4%.

Drilling down to today's options activity, 2,903 calls and 3,485 puts have swapped hands, or 16 times the intraday average volume. Most popular is the September 30 call.

The equity's Schaeffer's put/call open interest ratio (SOIR) of 1.52 stands in the 92nd percentile of readings from the past 12 months. This means short-term options traders have been much more bearish than usual. Plus, short interest makes up 7.3% of the stock's available float.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI